Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitors

Karthik V. Giridhar; Tait Shanafelt; Pritish K. Tosh; Sameer A. Parikh; Timothy G. Call

doi:10.1080/10428194.2016.1267352

Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitors

Karthik V. Giridhar, Tait Shanafelt, Pritish K. Tosh, Sameer A. Parikh, Timothy G. Call

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1973-1976
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	58
Issue number	8
DOIs	https://doi.org/10.1080/10428194.2016.1267352
State	Published - Aug 3 2017

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2016.1267352

Cite this

@article{50110c68d06f4a74b64f9781ffbc7b05,

title = "Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitors",

author = "Giridhar, {Karthik V.} and Tait Shanafelt and Tosh, {Pritish K.} and Parikh, {Sameer A.} and Call, {Timothy G.}",

note = "Funding Information: Dr. Shanafelt discloses research support from Pharmacyclics, Jannsen, GlaxoSmithKline, Genentech, Celgene, and Cephalon. Dr. Parikh notes research support from Pharmacyclics and he is on the advisory board of Pharmacyclics (no personal compensation).",

year = "2017",

month = aug,

day = "3",

doi = "10.1080/10428194.2016.1267352",

language = "English (US)",

volume = "58",

pages = "1973--1976",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "8",

}

TY - JOUR

T1 - Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitors

AU - Giridhar, Karthik V.

AU - Shanafelt, Tait

AU - Tosh, Pritish K.

AU - Parikh, Sameer A.

AU - Call, Timothy G.

N1 - Funding Information: Dr. Shanafelt discloses research support from Pharmacyclics, Jannsen, GlaxoSmithKline, Genentech, Celgene, and Cephalon. Dr. Parikh notes research support from Pharmacyclics and he is on the advisory board of Pharmacyclics (no personal compensation).

PY - 2017/8/3

Y1 - 2017/8/3

UR - http://www.scopus.com/inward/record.url?scp=85006152284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006152284&partnerID=8YFLogxK

U2 - 10.1080/10428194.2016.1267352

DO - 10.1080/10428194.2016.1267352

M3 - Editorial

C2 - 27960571

AN - SCOPUS:85006152284

SN - 1042-8194

VL - 58

SP - 1973

EP - 1976

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 8

ER -

Disseminated herpes zoster in chronic lymphocytic leukemia (CLL) patients treated with B-cell receptor pathway inhibitors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this